Identifying Cancer Genes in in Blood and Bone Marrow Samples From Patients With Acute Myeloid Leukemia November 7, 2026 Leukemia
Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia November 7, 2026 Leukemia
Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes November 7, 2026 Leukemia
Akt Inhibitor MK2206, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma November 7, 2026 Leukemia
Fludarabine Followed by Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia November 7, 2026 Leukemia
Venetoclax or Placebo in Combination With Reduced-Intensity Conditioning Hematopoietic Cell (Bone Marrow/Blood Stem Cell) Transplant and as Maintenance Therapy After Transplant in Patients With Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial) November 7, 2026 Leukemia
Genetics Study of Tissue Collected From Patients With Acute Myeloid Leukemia November 7, 2026 Leukemia
Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes November 7, 2026 Leukemia